Patents by Inventor Henrik Naested

Henrik Naested has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120264155
    Abstract: The present invention relates to an analytical method for quantitation of selected multiple recombinant proteins in a complex matrix such as recombinant polyclonal antibodies in serum or recombinant polyclonal antibodies expressed in a culture supernatant.
    Type: Application
    Filed: October 7, 2010
    Publication date: October 18, 2012
    Applicant: Symphogen A/S
    Inventors: Torben P. Frandsen, Henrik Naested, Jette Wagtberg Sen, Pernille Foged Jensen
  • Publication number: 20040172685
    Abstract: Uses of MAPK4, a member of the mitogen-activated protein (MAP) kinase family, are provided herein, based on the discovery that the MAPK4 negatively regulates the expression of genes associated with disease (e.g. PR-genes) and wound responses in plants such that the loss of MAPK4 function leads to their derepression. Methods are disclosed for controlling the growth of a plant and/or the expression of at least one wounding or pathogen response gene in said plant, the method comprising altering in the plant the level of the gene product of a MAPK4 gene. Furthermore, transgenic plants transformed with an MAPK4 construct and having enhanced wound and/or disease resistance are disclosed.
    Type: Application
    Filed: December 6, 2000
    Publication date: September 2, 2004
    Inventors: John Mundy, Anders Bogh Jensen, Morten Petersen, Henrik Naested, Peter Brodersen